title: Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.
abstract: BACKGROUND
  Acute non-A, non-B hepatitis after blood transfusion often progresses to chronic hepatitis and sometimes culminates in cirrhosis or even hepatocellular carcinoma. However, the frequency of these sequelae and their effects on mortality are not known.
  
  
  METHODS
  We traced patients with transfusion-related non-A, non-B hepatitis who had been identified in five major prospective studies conducted in the United States between 1967 and 1980. We matched each patient with two control subjects (identified as the first and second controls) who received transfusions but who did not have hepatitis. The mortality rates in the three groups were determined with use of data from the National Death Index and Social Security Death Tapes. Cause-specific mortality was determined by reviewing death certificates.
  
  
  RESULTS
  Vital status was established for over 94 percent of the 568 patients who had had non-A, non-B hepatitis and the two control groups (526 first controls and 458 second controls). After an average follow-up of 18 years, the estimate by life-table analysis of mortality from all causes was 51 percent for those with transfusion-associated non-A, non-B hepatitis, as compared with 52 percent for the first controls and 50 percent for the second controls. The survival curves for the three groups were virtually the same. Mortality related to liver disease was 3.3, 1.1, and 2.0 percent, respectively, among the three groups (P = 0.033 for the comparison of the group with non-A, non-B hepatitis with the combined control group). Seventy-one percent of the deaths related to liver disease occurred among patients with chronic alcoholism.
  
  
  CONCLUSIONS
  In this long-term follow-up study, there was no increase in mortality from all causes after transfusion-associated non-A, non-B hepatitis, although there was a small but statistically significant increase in the number of deaths related to liver disease.
authors.affiliation: Veterans Affairs Medical Center, Washington, DC 20422.
authors.forename: L B
authors.initials: LB
authors.lastname: Seeff
authors.forename: Z
authors.initials: Z
authors.lastname: Buskell-Bales
authors.forename: E C
authors.initials: EC
authors.lastname: Wright
authors.forename: S J
authors.initials: SJ
authors.lastname: Durako
authors.forename: H J
authors.initials: HJ
authors.lastname: Alter
authors.forename: F L
authors.initials: FL
authors.lastname: Iber
authors.forename: F B
authors.initials: FB
authors.lastname: Hollinger
authors.forename: G
authors.initials: G
authors.lastname: Gitnick
authors.forename: R G
authors.initials: RG
authors.lastname: Knodell
authors.forename: R P
authors.initials: RP
authors.lastname: Perrillo
mesh_terms: D000437:Alcoholism / Q000150:complications; D002423:Cause of Death; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000401:mortality* / Q000635:transmission*; D006801:Humans; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015996:Survival Rate; D065227:Transfusion Reaction